Corbus Pharmaceuticals Holdings, Inc. (CRBP) Executive Compensation
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRBP
CIK: 1595097
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMarc Fogarty
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001193125-26-422437 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-30 | — | SCHEDULE 13G Filing | 0001346824-26-000243 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | 4 | 0001193125-26-392093 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001193125-26-389829 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-16 | 4 | 0001193125-26-354145 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097066 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-11 | 4 | 0001193125-26-346966 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | 4 | 0001193125-26-342485 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | 4 | 0001193125-26-342479 | View SEC Doc Filr Page |
| 424B5 | 2026-08-07 | — | 424B5 | 0001193125-26-340378 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001972481-26-000255 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001972481-26-000254 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338274 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336864 | View SEC Doc Filr Page |
| 3 | 2026-08-04 | 2026-08-03 | 3 | 0001193125-26-332936 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002244 | View SEC Doc Filr Page |
| 144 | 2026-07-27 | — | 144 Filing | 0001972481-26-000237 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-02 | 8-K | 0001193125-26-295622 | View SEC Doc Filr Page |
| S-8 | 2026-06-17 | — | S-8 | 0001193125-26-274226 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267672 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267655 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267671 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-02 | 4 | 0001193125-26-255834 | View SEC Doc Filr Page |
| S-8 | 2026-05-29 | — | S-8 | 0001193125-26-248550 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-26 | 8-K | 0001193125-26-238059 | View SEC Doc Filr Page |